BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kanafi MM, Tavallaei M. Overview of advances in CRISPR/deadCas9 technology and its applications in human diseases. Gene 2022;830:146518. [PMID: 35447246 DOI: 10.1016/j.gene.2022.146518] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Boti MA, Athanasopoulou K, Adamopoulos PG, Sideris DC, Scorilas A. Recent Advances in Genome-Engineering Strategies. Genes (Basel) 2023;14. [PMID: 36672870 DOI: 10.3390/genes14010129] [Reference Citation Analysis]
2 Madhi ZS, Shallan MA, Almaamuri AM, Alhussainy AA, Al- Salih SSS, Raheem AK, Alwan HJ, Jalil AT. Lipids and lipid derivatives for delivery of the CRISPR/Cas9 system. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103948] [Reference Citation Analysis]
3 Chen K, Shen Z, Wang G, Gu W, Zhao S, Lin Z, Liu W, Cai Y, Mushtaq G, Jia J, Wan C(, Yan T. Research progress of CRISPR-based biosensors and bioassays for molecular diagnosis. Front Bioeng Biotechnol 2022;10:986233. [DOI: 10.3389/fbioe.2022.986233] [Reference Citation Analysis]
4 Heidersbach AJ, Dorighi KM, Gomez JA, Jacobi AM, Haley B. A versatile, high-efficiency platform for CRISPR-based gene activation.. [DOI: 10.1101/2022.07.21.501015] [Reference Citation Analysis]